Katharine Louise Lewis

19PUBLICATIONS
141CO-AUTHORS
Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)AllergyCancer therapy (excl. chemotherapy and radiation therapy)Autoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 11, 2026
High-Dose Methotrexate as CNS Prophylaxis in Ultra High-Risk Large B-Cell Lymphoma: An International Multicenter Analysis.

|Feb 05, 2026
Mosunetuzumab monotherapy is active and tolerable in patients with relapsed/refractory Richter transformation.

Katharine Louise Lewis, Sarit E Assouline, Ross Ian Baker

|Jan 07, 2026
Impact of prior bendamustine exposure on bispecific antibody outcomes in relapsed/refractory follicular lymphoma.

Gloria Iacoboni, Emil Ramsø Kyvsgaard, Víctor Navarro Garcés

|Dec 07, 2025
Pirtobrutinib Versus Ibrutinib in Treatment-Naïve and Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.

Jennifer A Woyach, Lugui Qiu, Sebastian Grosicki

|Nov 06, 2025
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas.

Daniel Fasser, Greta Joy, Mark R Dowling

|May 06, 2025
An international real-world study of primary vitreoretinal lymphoma from the Australasian lymphoma alliance and collaborators.

Catherine Tang, Catriona Downie, Mandeep S Sagoo

Pageof 4

Frequent Collaborators

14 joint publications

Chan Yoon Cheah

5 joint publications

Matthew Ku

4 joint publications

Nada Hamad

4 joint publications

Diego Villa